Policy pathway
Efficiently moving a health intervention from development to use
For a new vaccine or intervention, the road to introduction in developing countries has been complex, long, and for the most part, uncharted. Moving a vaccine along that road requires collaboration between manufacturers, international organizations, national authorities, and various expert bodies. With the world closer than it’s ever been to a first malaria vaccine, MVI has been working with public and private organizations involved in the global health process to create a map for the introduction of vaccines and other new interventions in developing countries.
This map—or policy pathway—is meant to allow for the most efficient movement of a product from development to national decision-making and use. Working with partners, MVI is engaged in activities to accomplish the following:
- To define areas along the pathway that could be streamlined.
- To identify actions within and among organizations that could be done in parallel to one another to speed the process.
- To define roles and accountabilities of different organizations along the pathway.
A critical part of the policy pathway is defining the data that key global institutions will need to take a policy decision. In 2008, MVI analyzed the data the World Health Organization required for past malaria and immunization interventions and the data it therefore may require for malaria vaccines. Download and read the Analysis of WHO Policy Development Processes for a New Intervention (255 KB PDF).
